Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry
Rachel Cusatis(Medical College of Wisconsin), Bronwen E. Shaw(Medical College of Wisconsin), Kristin Page(Medical College of Wisconsin), Rafeek A. Yusuf(National Marrow Donor Program), Stephanie J. Lee(Fred Hutch Cancer Center), Othman Salim Akhtar(Roswell Park Comprehensive Cancer Center), Idayat Akinola(Medical College of Wisconsin), Deborah Mattila(National Marrow Donor Program), Mary Hengen(National Marrow Donor Program), Kathryn E. Flynn(Medical College of Wisconsin), Patricia Steinert(Medical College of Wisconsin), Yung‐Tsi Bolon(National Marrow Donor Program), Heather E. Stefanski(National Marrow Donor Program), Michelle Kuxhausen(National Marrow Donor Program), Caitrin Bupp(National Marrow Donor Program), Stephen R. Spellman(National Marrow Donor Program), Keming Zhan(Medical College of Wisconsin), Samantha Jaglowski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Mariam Allbee‐Johnson(Medical College of Wisconsin), Eileen Tuschl(Medical College of Wisconsin), Marcelo C. Pasquini(Medical College of Wisconsin), Amy Moskop(Medical College of Wisconsin), Jenni Bloomquist(National Marrow Donor Program), Larisa Broglie(Medical College of Wisconsin), Min Chen(Medical College of Wisconsin), Manmeet Kaur(Medical College of Wisconsin), Rachel Phelan(Medical College of Wisconsin), Miranda Kapfhammer(Medical College of Wisconsin), Zhongyu Feng(Medical College of Wisconsin), Jeffery J Auletta(National Marrow Donor Program), Mehdi Hamadani(Medical College of Wisconsin), Wael Saber(Medical College of Wisconsin), Carlos Litovich(Medical College of Wisconsin), Doug Rizzo(Medical College of Wisconsin), Steven M. Devine(National Marrow Donor Program)
Cited by 68
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
|Journal of Clinical Oncology|2006|2k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
|Journal of Clinical Oncology|2017|664